Found: 55
Select item for more details and to access through your institution.
Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Blood Test for Breast Cancer Screening through the Detection of Tumor-Associated Circulating Transcripts.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 9140, doi. 10.3390/ijms23169140
- By:
- Publication type:
- Article
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 3, p. 743, doi. 10.1007/s10549-020-05891-0
- By:
- Publication type:
- Article
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 183, n. 1, p. 107, doi. 10.1007/s10549-020-05750-y
- By:
- Publication type:
- Article
Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 3, p. 687, doi. 10.1007/s10549-019-05505-4
- By:
- Publication type:
- Article
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11).
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 367, doi. 10.1007/s10549-019-05400-y
- By:
- Publication type:
- Article
Prediction of short- and long-term survival for advanced cancer patients after ICU admission.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 6, p. 1647, doi. 10.1007/s00520-014-2519-2
- By:
- Publication type:
- Article
Genomic landscape of extraordinary responses in metastatic breast cancer.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01973-x
- By:
- Publication type:
- Article
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15).
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359231225029
- By:
- Publication type:
- Article
Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation.
- Published in:
- Experimental & Molecular Medicine EMM, 2024, v. 56, n. 4, p. 987, doi. 10.1038/s12276-024-01210-5
- By:
- Publication type:
- Article
Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 5, p. 878, doi. 10.1007/s10147-015-0798-3
- By:
- Publication type:
- Article
Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor--Positive Metastatic Breast Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1198, doi. 10.4143/crt.2022.1543
- By:
- Publication type:
- Article
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1096, doi. 10.4143/crt.2022.1565
- By:
- Publication type:
- Article
A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03).
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 523, doi. 10.4143/crt.2022.1360
- By:
- Publication type:
- Article
Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09).
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 123, doi. 10.4143/crt.2021.1561
- By:
- Publication type:
- Article
Talazoparib versus Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 4, p. 1084, doi. 10.4143/crt.2020.1381
- By:
- Publication type:
- Article
Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 3, p. 907, doi. 10.4143/crt.2019.713
- By:
- Publication type:
- Article
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1527, doi. 10.4143/crt.2018.598
- By:
- Publication type:
- Article
Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 3, p. 801, doi. 10.4143/crt.2017.210
- By:
- Publication type:
- Article
Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 2, p. 423, doi. 10.4143/crt.2016.191
- By:
- Publication type:
- Article
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061989
- By:
- Publication type:
- Article
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061989
- By:
- Publication type:
- Article
On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-022-01601-4
- By:
- Publication type:
- Article
Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120320
- By:
- Publication type:
- Article
Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045127
- By:
- Publication type:
- Article
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03782-7
- By:
- Publication type:
- Article
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00289-7
- By:
- Publication type:
- Article
Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2405, doi. 10.3390/cancers14102405
- By:
- Publication type:
- Article
Chemotherapy-induced irreversible alopecia in early breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 3, p. 527, doi. 10.1007/s10549-017-4204-x
- By:
- Publication type:
- Article
Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 2, p. 255, doi. 10.1007/s10549-017-4175-y
- By:
- Publication type:
- Article
Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1409, doi. 10.1002/cam4.5022
- By:
- Publication type:
- Article
Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.689587
- By:
- Publication type:
- Article
Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis.
- Published in:
- Breast Care, 2020, v. 15, n. 4, p. 408, doi. 10.1159/000503847
- By:
- Publication type:
- Article
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Increased resting-state cerebellar-cortical connectivity in breast cancer survivors with cognitive complaints after chemotherapy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91447-1
- By:
- Publication type:
- Article
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor‐positive, HER2‐negative metastatic breast cancer.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 4, p. 917, doi. 10.1002/ijc.33613
- By:
- Publication type:
- Article
Molecular alterations and poziotinib efficacy, a pan‐HER inhibitor, in human epidermal growth factor receptor 2 (HER2)‐positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2‐positive breast cancer patients
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 6, p. 1669, doi. 10.1002/ijc.32188
- By:
- Publication type:
- Article
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 5, p. 1179, doi. 10.1002/ijc.32020
- By:
- Publication type:
- Article
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0152585
- By:
- Publication type:
- Article
Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0149347
- By:
- Publication type:
- Article
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
- Published in:
- Yonsei Medical Journal, 2017, v. 58, n. 1, p. 19, doi. 10.3349/ymj.2017.58.1.19
- By:
- Publication type:
- Article
Effect of primary tumor resection on overall survival in patients with stage IV breast cancer.
- Published in:
- Breast Journal, 2019, v. 25, n. 5, p. 908, doi. 10.1111/tbj.13344
- By:
- Publication type:
- Article
Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02903-x
- By:
- Publication type:
- Article
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1015, doi. 10.1111/cts.12965
- By:
- Publication type:
- Article
Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer.
- Published in:
- Oncology, 2011, v. 79, n. 5/6, p. 324, doi. 10.1159/000322192
- By:
- Publication type:
- Article
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00684-w
- By:
- Publication type:
- Article
Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e243, doi. 10.1634/theoncologist.2019-0551
- By:
- Publication type:
- Article